TAG:
lab sales
Where Will “Free Tests” Take the Lab Industry?
By Robert Michel | From the Volume X No. 16 – December 1, 2003 Issue
CEO SUMMARY: In the absence of public discussion, continued use of the “free testing” strategy by the nation’s more aggressive laboratory companies could trigger some unpleasant consequences that would affect all laboratories and pathology group practices. Five questions, presented he…
Lab Sales & Marketing Programs Are Changing
By Robert Michel | From the Volume VIII No. 2 – February 5, 2001 Issue
CEO SUMMARY: Market evidence points to a shifting role in the sales priorities of the national labs. Meanwhile, regional laboratories and pathology companies are enjoying surprising success with their sales and marketing programs. These shifting patterns may indicate a new stratification …
Quest Diagnostics Emphasizes Venture Capital Investments
By Robert Michel | From the Volume VII No. 13 – September 11, 2000 Issue
ONE SIGNIFICANT business strategy in play at Quest Diagnostics Incorporated is venture capital investing. With $3 billion in sales, Quest Diagnostics is the largest clinical laboratory company in the United States. It understands that the traditional lab sales strategy of marketing …
Genesis Clinical Laboratory Hits Outreach Home Run
By Robert Michel | From the Volume VII No. 12 – August 21, 2000 Issue
CEO SUMMARY: Commercial laboratory consolidation has left Chicago with only a handful of laboratory providers. New management at MacNeal Hospital’s for-profit laboratory division recognized this opportunity. During the past three years, the outreach program was revitalized and the sales…
Lab Industry Attracting New Investment Dollars
By Robert Michel | From the Volume VII No. 11 – July 31, 2000 Issue
CEO SUMMARY: Professional investors with access to hundreds of millions of dollars of investment capital are closely scrutinizing the clinical laboratory industry. They are encouraged by the recent financial performance of public laboratory companies. For independent laboratory owners, th…
LabCorp Buys Two More California Laboratories
By Robert Michel | From the Volume VII No. 7 – May 8, 2000 Issue
CEO SUMMARY: Laboratory Corporation of America is serving notice that it intends to increase its competitive presence in California, the largest market for diagnostic testing in the United States. It recently signed agreements to purchase two respected independent laboratory companies, on…
Ten Myths of Lab Management That Led the Clinical Lab Industry Astray
By Robert Michel | From the Volume VI No. 11 – August 9, 1999 Issue
Part One of a Special Series CEO SUMMARY: One of our most popular series ever was the “13 Perilous Parallels” of laboratory management. This four-part story appeared in 1996 and chronicled similar management strategies used by various national laboratories during the…
Labs Entering New Cycle Of Evolution and Change
By Robert Michel | From the Volume VI No. 6 – April 26, 1999 Issue
CEO SUMMARY: As some of the nation’s most astute and forward-looking lab executives prepare to gather in New Orleans for the fourth annual EXECUTIVE WAR COLLEGE, it is time to share our assessment of the laboratory and pathology industry. Recent events presage another profound …
Client Service and Sales Fuel Fast Growth at AML
By Robert Michel | From the Volume VI No. 5 – April 5, 1999 Issue
CEO SUMMARY: Here’s proof positive that effective management can make a positive difference in the financial performance of clinical labs. Upon taking title to American Medical Laboratories in the spring of 1997, its new owners used an emphasis on “customer-first” service and aggres…
Sales to Become the Secret Behind Successful Labs
By R. Lewis Dark | From the Volume VI No. 4 – March 15, 1999 Issue
SALES WILL BECOME A NECESSARY PART of every laboratory executive’s management toolbox during the next few years. The unmistakable success of the nation’s best-performing laboratories now rests on their effective use of sales and marketing programs. This is not something that most hospital labora…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized